(Q37859348)

24 August 2017

1 reference

title

Cancer biomarker discovery: Opportunities and pitfalls in analytical methods (English)

1 reference

24 August 2017

0 references

Haleem J Issaq

1

1 reference

24 August 2017

Timothy J Waybright

series ordinal

2

1 reference

24 August 2017

Timothy D Veenstra

series ordinal

3

1 reference

24 August 2017

publication date

30 March 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

32

1 reference

24 August 2017

issue

9

1 reference

24 August 2017

page(s)

967-975

1 reference

The accuracy of urinary cytology in daily practice

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Clinical states model for biomarkers in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Non-invasive diagnostic tests for bladder cancer: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Developing biomarkers for improved diagnosis and treatment outcome monitoring of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Molecular markers in bladder cancer: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Phases of biomarker development for early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Tumor markers in the diagnosis of primary bladder cancer. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Urine-based assays for the detection of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Serum CEA and CA 15-3 as prognostic factors in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Analysis of the adult human plasma metabolome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

An investigation into the human serum "interactome"

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Characterization of the low molecular weight human serum proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

The human plasma proteome: a nonredundant list developed by combination of four separate sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

A model for random sampling and estimation of relative protein abundance in shotgun proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Comparative evaluation of mass spectrometry platforms used in large-scale proteomics investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Does the mass spectrometer define the marker? A comparison of global metabolite profiling data generated simultaneously via UPLC-MS on two different mass spectrometers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Noninvasive urinary metabonomic diagnosis of human bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Urine metabolomics analysis for kidney cancer detection and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

A comprehensive urinary metabolomic approach for identifying kidney cancerr

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Pathway analysis of kidney cancer using proteomics and metabolic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Analysis of metabolomic data using support vector machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Comparison of 1D and 2D NMR spectroscopy for metabolic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Comprehensive Two-Dimensional Gas Chromatography using an On-Column Thermal Modulator Interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Improved analysis of multivariate data by variable stability scaling: application to NMR-based metabolic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

Are biomarkers for bladder cancer beneficial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

7 January 2021

Combinations of urine-based tumour markers in bladder cancer surveillance

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

7 January 2021

Differences in metabolite profile between blood plasma and serum

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

7 January 2021

Direct ampholyte-free liquid-phase isoelectric peptide focusing: application to the human serum proteome

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

7 January 2021

Cross-platform comparison of methods for quantitative metabolomics of primary metabolism

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

7 January 2021

Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

7 January 2021

Cancer biomarker discovery in plasma using a tissue-targeted proteomic approach

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000588

7 January 2021

Identifiers

DOI

10.1002/ELPS.201000588

1 reference

24 August 2017

1 reference